GENinCode Plc (AIM:GENI)
London · Delayed Price · Currency is GBP · Price in GBX 0.8770
-0.0730 (-7.68%)
Sep 11, 2026, 4:26 PM GMT
GENinCode Market Cap
GENinCode has a market cap or net worth of 6.4 million as of September 11, 2026. Its market cap has increased by 43.95% in one year.
Market Cap
6.40M
Enterprise Value
5.72M
Revenue
3.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.88
ChartMarket Cap Chart
Since July 22, 2021, GENinCode's market cap has decreased from 40.72M to 6.40M, a decrease of -84.28%. That is a compound annual growth rate of -30.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 6.40M | -7.03% |
| Dec 31, 2025 | 6.89M | 2.39% |
| Dec 31, 2024 | 6.72M | 33.68% |
| Dec 29, 2023 | 5.03M | -32.26% |
| Dec 30, 2022 | 7.43M | -76.15% |
| Dec 31, 2021 | 31.14M | -23.53% |
| Jul 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 181.59B |
| GSK plc | 70.94B |
| Haleon | 29.40B |
| Smith & Nephew | 8.48B |
| Solvonis Therapeutics | 7.83M |
| OptiBiotix Health | 6.56M |
| Cizzle Biotechnology Holdings | 6.37M |
| CRISM Therapeutics | 6.10M |